These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11478788)

  • 1. Identification of N(omega)-carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and diabetes.
    Odani H; Iijima K; Nakata M; Miyata S; Kusunoki H; Yasuda Y; Hiki Y; Irie S; Maeda K; Fujimoto D
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1232-6. PubMed ID: 11478788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of N(omega)-carboxymethylarginine as a novel acid-labileadvanced glycation end product in collagen.
    Iijima K; Murata M; Takahara H; Irie S; Fujimoto D
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):23-7. PubMed ID: 10727397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amount of N(omega)-(Carboxymethyl)arginine generated in collagen and bovine serum albumin during glycation reactions is significantly different.
    Iijima K; Fujimoto D; Irie S
    Connect Tissue Res; 2007; 48(5):271-6. PubMed ID: 17882703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological detection of N omega-(Carboxymethyl)arginine by a specific antibody.
    Mera K; Fujiwara Y; Otagiri M; Sakata N; Nagai R
    Ann N Y Acad Sci; 2008 Apr; 1126():155-7. PubMed ID: 18079475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of N epsilon-(carboxymethyl)lysine in exhaled breath condensate using isotope dilution liquid chromatography/electrospray ionization tandem mass spectrometry.
    Gonzalez-Reche LM; Kucharczyk A; Musiol AK; Kraus T
    Rapid Commun Mass Spectrom; 2006; 20(18):2747-52. PubMed ID: 16921564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction.
    Odani H; Shinzato T; Matsumoto Y; Usami J; Maeda K
    Biochem Biophys Res Commun; 1999 Mar; 256(1):89-93. PubMed ID: 10066428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins.
    Zeng J; Davies MJ
    Chem Res Toxicol; 2005 Aug; 18(8):1232-41. PubMed ID: 16097796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.
    Thornalley PJ; Battah S; Ahmed N; Karachalias N; Agalou S; Babaei-Jadidi R; Dawnay A
    Biochem J; 2003 Nov; 375(Pt 3):581-92. PubMed ID: 12885296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes.
    Han Y; Randell E; Vasdev S; Gill V; Curran M; Newhook LA; Grant M; Hagerty D; Schneider C
    Clin Biochem; 2009 May; 42(7-8):562-9. PubMed ID: 19154730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of advanced glycation end products in NIDDM patients with diabetic complications.
    Ono Y; Aoki S; Ohnishi K; Yasuda T; Kawano K; Tsukada Y
    Diabetes Care; 1998 Jun; 21(6):1027. PubMed ID: 9614627
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Products of advanced glycation in patients with type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Pokupec R; Turk N; Stavljenić-Rukavina A
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):552-9. PubMed ID: 14503994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products/peptides: an in vivo investigation.
    Lapolla A; Fedele D; Reitano R; Bonfante L; Pastori G; Seraglia R; Tubaro M; Traldi P
    Ann N Y Acad Sci; 2005 Jun; 1043():267-75. PubMed ID: 16037247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric study of in vivo production of advanced glycation end-products/peptides.
    Lapolla A; Fedele D; Reitano R; Bonfante L; Guizzo M; Seraglia R; Tubaro M; Traldi P
    J Mass Spectrom; 2005 Jul; 40(7):969-72. PubMed ID: 15768376
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Kinoshita S; Mera K; Ichikawa H; Shimasaki S; Nagai M; Taga Y; Iijima K; Hattori S; Fujiwara Y; Shirakawa JI; Nagai R
    Oxid Med Cell Longev; 2019; 2019():9073451. PubMed ID: 31583049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of antibodies for evaluating the biological significance of AGEs.
    Nagai R; Fujiwara Y; Mera K; Motomura K; Iwao Y; Tsurushima K; Nagai M; Takeo K; Yoshitomi M; Otagiri M; Ikeda T
    Ann N Y Acad Sci; 2008 Apr; 1126():38-41. PubMed ID: 18079488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry for the study of protein glycation in disease.
    Niwa T
    Mass Spectrom Rev; 2006; 25(5):713-23. PubMed ID: 16526005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
    Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
    J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes.
    Nakamura N; Yamazaki K; Satoh A; Urakaze M; Kobayashi M; Yamabe H; Osawa H; Shirato K; Sugawara T; Nakamura M; Tamura M; Okumura K
    In Vivo; 2003; 17(2):177-80. PubMed ID: 12792982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.